- Home
- SIMO vs DNLI Comparison
SIMO vs DNLI Comparison
Compare SIMO & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIMO
- DNLI
- Stock Information
- Founded
- SIMO 1995
- DNLI 2013
- Country
- SIMO Hong Kong
- DNLI United States
- Employees
- SIMO N/A
- DNLI N/A
- Industry
- SIMO Semiconductors
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SIMO Technology
- DNLI Health Care
- Exchange
- SIMO Nasdaq
- DNLI Nasdaq
- Market Cap
- SIMO 2.3B
- DNLI 2.1B
- IPO Year
- SIMO 2005
- DNLI 2017
- Fundamental
- Price
- SIMO $69.96
- DNLI $13.89
- Analyst Decision
- SIMO Strong Buy
- DNLI Strong Buy
- Analyst Count
- SIMO 8
- DNLI 15
- Target Price
- SIMO $80.63
- DNLI $33.85
- AVG Volume (30 Days)
- SIMO 380.7K
- DNLI 1.6M
- Earning Date
- SIMO 07-31-2025
- DNLI 07-31-2025
- Dividend Yield
- SIMO 2.86%
- DNLI N/A
- EPS Growth
- SIMO 59.19
- DNLI N/A
- EPS
- SIMO 2.80
- DNLI N/A
- Revenue
- SIMO $780,733,000.00
- DNLI N/A
- Revenue This Year
- SIMO $2.23
- DNLI N/A
- Revenue Next Year
- SIMO $13.23
- DNLI $335.74
- P/E Ratio
- SIMO $25.56
- DNLI N/A
- Revenue Growth
- SIMO 10.84
- DNLI N/A
- 52 Week Low
- SIMO $37.21
- DNLI $10.57
- 52 Week High
- SIMO $85.87
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- SIMO 67.74
- DNLI 45.02
- Support Level
- SIMO $66.07
- DNLI $14.19
- Resistance Level
- SIMO $70.18
- DNLI $14.88
- Average True Range (ATR)
- SIMO 1.85
- DNLI 0.77
- MACD
- SIMO -0.08
- DNLI -0.03
- Stochastic Oscillator
- SIMO 80.49
- DNLI 34.55
About SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.